UCB, Novartis sales and marketing update

UCB and Novartis extended to 2014 a co-distribution agreement for cardiovascular drug Provas valsartan in Germany. UCB also received exclusive, German rights to the pharma's hypertension drugs Dafiro valsartan/amlodipine and Dafiro HCT. Further terms were not disclosed. ...